Publications by authors named "David L Veenstra"

100Publications

Genetic Variant Reinterpretation: Economic and Population Health Management Challenges.

Popul Health Manag 2020 Sep 9. Epub 2020 Sep 9.

Department of Psychiatry, Columbia University Vagelos College of Physicians & Surgeons, NY State Psychiatric Institute, New York, New York, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/pop.2020.0115DOI Listing
September 2020

Provider preferences for resolving uncertainty and avoiding harms in precision medicine: a discrete choice experiment.

Per Med 2020 09 17;17(5):389-398. Epub 2020 Aug 17.

The Comparative Health Outcomes, Policy, & Economics (CHOICE) Institute, University of Washington, Seattle, WA 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pme-2020-0018DOI Listing
September 2020

Cost-Effectiveness of Cannabidiol Adjunct Therapy versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome.

Pharmacoeconomics 2020 Nov;38(11):1237-1245

Department of Pharmacy, The Comparative Health Outcomes, Policy and Economics (CHOICE) Institute, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40273-020-00945-zDOI Listing
November 2020

Economic value of exome sequencing for suspected monogenic disorders.

Genet Med 2020 Jun 30. Epub 2020 Jun 30.

The Comparative Health Outcomes, Policy & Economics (CHOICE) Institute, Department of Pharmacy, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41436-020-0888-0DOI Listing
June 2020

Medication persistence of targeted immunomodulators for plaque psoriasis: A retrospective analysis using a U.S. claims database.

Pharmacoepidemiol Drug Saf 2020 06 4;29(6):675-683. Epub 2020 May 4.

Department of Pharmacy, The Comparative Health Outcomes, Policy & Economics (CHOICE) Institute, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pds.5021DOI Listing
June 2020

Payer Preferences and Willingness to Pay for Genomic Precision Medicine: A Discrete Choice Experiment.

J Manag Care Spec Pharm 2020 Apr;26(4):529-537

The Comparative Health Outcomes, Policy & Economics (CHOICE) Institute, University of Washington School of Pharmacy, Seattle.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18553/jmcp.2020.26.4.529DOI Listing
April 2020

Health Economics Tools and Precision Medicine: Opportunities and Challenges.

Forum Health Econ Policy 2020 Mar 5;23(1). Epub 2020 Mar 5.

Hutchinson Cancer Research Center, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/fhep-2019-0013DOI Listing
March 2020

Providers' perceptions on barriers and facilitators to prescribing naloxone for patients at risk for opioid overdose after implementation of a national academic detailing program: A qualitative assessment.

Res Social Adm Pharm 2020 Aug 31;16(8):1033-1040. Epub 2019 Oct 31.

The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, Seattle, WA, USA; Department of Health Services, School of Public Health, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.sapharm.2019.10.015DOI Listing
August 2020

Are There Different Evidence Thresholds for Genomic Versus Clinical Precision Medicine? A Value of Information-Based Framework Applied to Antiplatelet Drug Therapy.

Value Health 2019 09 1;22(9):988-994. Epub 2019 Aug 1.

The Comparative Health Outcomes, Policy & Economics (CHOICE) Institute, Department of Pharmacy, University of Washington, Seattle, WA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2019.03.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6746330PMC
September 2019

Demand for Precision Medicine: A Discrete-Choice Experiment and External Validation Study.

Pharmacoeconomics 2020 01;38(1):57-68

The Comparative Health Outcomes, Policy and Economics (CHOICE) Institute, Department of Pharmacy, University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40273-019-00834-0DOI Listing
January 2020

Implementation evaluation of academic detailing on naloxone prescribing trends at the United States Veterans Health Administration.

Health Serv Res 2019 10 17;54(5):1055-1064. Epub 2019 Jul 17.

The Comparative Health Outcomes, Policy, & Economics (CHOICE) Institute, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/1475-6773.13194DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736912PMC
October 2019

Cost-effectiveness of population genomic screening.

Genet Med 2019 12;21(12):2840-2841

Geisinger, Danville, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41436-019-0580-4DOI Listing
December 2019

Do cancer treatments have option value? Real-world evidence from metastatic melanoma.

Health Econ 2019 07;28(7):855-867

Comparative Health Outcomes, Policy and Economics (CHOICE) Institute, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hec.3899DOI Listing
July 2019

The Feelings About genomiC Testing Results (FACToR) Questionnaire: Development and Preliminary Validation.

J Genet Couns 2019 04 14;28(2):477-490. Epub 2018 Dec 14.

Department of Health Services, School of Public Health, University of Washington, Box 357660, Seattle, WA, 98195-7660, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10897-018-0286-9DOI Listing
April 2019

How can clinical researchers quantify the value of their proposed comparative research?

Am Heart J 2019 03 8;209:116-125. Epub 2018 Dec 8.

Division of Cardiology, Department of Medicine, University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ahj.2018.12.003DOI Listing
March 2019

Cost-Effectiveness of Targeted Pharmacotherapy for Moderate to Severe Plaque Psoriasis.

J Manag Care Spec Pharm 2018 Dec;24(12):1210-1217

1 Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, Seattle.

View Article

Download full-text PDF

Source
https://www.jmcp.org/doi/10.18553/jmcp.2018.24.12.1210
Publisher Site
http://dx.doi.org/10.18553/jmcp.2018.24.12.1210DOI Listing
December 2018

Considerations in initiating genomic screening programs in health care systems.

Nurs Outlook 2018 11 11;66(6):570-575. Epub 2018 Jul 11.

American Academy of Nursing, Washington D.C.; National Institute of Nursing Research, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.outlook.2018.06.008DOI Listing
November 2018

Patient preferences for massively parallel sequencing genetic testing of colorectal cancer risk: a discrete choice experiment.

Eur J Hum Genet 2018 09 25;26(9):1257-1265. Epub 2018 May 25.

Canadian Centre for Applied Research in Cancer Control (ARCC), Cancer Control Research, British Columbia Cancer, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41431-018-0161-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6117311PMC
September 2018

Financial benefit of a smoking cessation program prior to elective colorectal surgery.

J Surg Res 2017 07 7;215:183-189. Epub 2017 Apr 7.

Department of Surgery, University of Washington, Seattle, Washington; Surgical Outcomes Research Center, Department of Surgery, University of Washington, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jss.2017.03.067DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5526103PMC
July 2017

Dependency and health utilities in stroke: Data to inform cost-effectiveness analyses.

Eur Stroke J 2017 Mar 1;2(1):70-76. Epub 2017 Mar 1.

Institute of Cardiovascular & Medical Sciences, University of Glasgow, BHF Cardiovascular Research Centre, Glasgow, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2396987316683780DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027777PMC
March 2017

What is the value of conducting a trial of r-tPA for the treatment of mild stroke patients?

Int J Stroke 2017 02 10;12(2):137-144. Epub 2016 Oct 10.

1 Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1747493016669887DOI Listing
February 2017

Risk-Benefit Analysis of Pediatric-Inspired Versus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Protocols for Acute Lymphoblastic Leukemia in Adolescents and Young Adults.

J Adolesc Young Adult Oncol 2017 Mar 25;6(1):53-61. Epub 2016 Oct 25.

1 Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy, University of Washington , Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/jayao.2016.0049DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5346961PMC
March 2017

Impact of Body Mass Index and Genetics on Warfarin Major Bleeding Outcomes in a Community Setting.

Am J Med 2017 02 2;130(2):222-228. Epub 2016 Sep 2.

Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, Wash; Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, Wash. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjmed.2016.08.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5263176PMC
February 2017

Predicting Low Accrual in the National Cancer Institute's Cooperative Group Clinical Trials.

J Natl Cancer Inst 2016 Feb 29;108(2). Epub 2015 Dec 29.

Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA (CSB, SDR, CLM, JJC, AB, DLV) and the Hutchinson Institute for Outcomes Research, Fred Hutchinson Cancer Research Center (SDR).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv324DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5964887PMC
February 2016

Next Generation Sequencing in the Clinic: a Patterns of Care Study in a Retrospective Cohort of Subjects Referred to a Genetic Medicine Clinic for Suspected Lynch Syndrome.

J Genet Couns 2016 06 5;25(3):515-9. Epub 2015 Dec 5.

Department of Medicine, Division of Medical Genetics, University of Washington, 1705 NE Pacific Street, K228, UW Box 357720, Seattle, WA, 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10897-015-9902-0DOI Listing
June 2016

A Framework for Prioritizing Research Investments in Precision Medicine.

Med Decis Making 2016 07 26;36(5):567-80. Epub 2015 Oct 26.

Department of Pharmacy, Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, USA (AB, JJC, DLV)

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/0272989X15610780
Publisher Site
http://dx.doi.org/10.1177/0272989X15610780DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845804PMC
July 2016

Improving the Efficiency and Quality of the Value Assessment Process for Companion Diagnostic Tests: The Companion test Assessment Tool (CAT).

J Manag Care Spec Pharm 2015 Aug;21(8):700-12

University of Washington, H375 HSB Box 357630, 1959 N.E. Pacific St., Seattle, WA 98195-7630.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18553/jmcp.2015.21.8.700DOI Listing
August 2015

Alcohol misuse, genetics, and major bleeding among warfarin therapy patients in a community setting.

Pharmacoepidemiol Drug Saf 2015 Jun 8;24(6):619-27. Epub 2015 Apr 8.

Group Health Research Institute, Group Health, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pds.3769DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478047PMC
June 2015

Response to Phillips et al.

Genet Med 2015 Apr;17(4):315

Department of Pharmacy, Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/gim.2015.11DOI Listing
April 2015

Design, implementation, and first-year outcomes of a value-based drug formulary.

J Manag Care Spec Pharm 2015 Apr;21(4):269-75

University of Washington, 1959 N.E. Pacific Ave., Seattle, WA 98196.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18553/jmcp.2015.21.4.269DOI Listing
April 2015

The cost-effectiveness of returning incidental findings from next-generation genomic sequencing.

Genet Med 2015 Jul 13;17(7):587-95. Epub 2014 Nov 13.

1] Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, Washington, USA [2] Institute for Public Health Genetics, University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/gim.2014.156DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4430464PMC
July 2015

Tumor marker usage and medical care costs among older early-stage breast cancer survivors.

J Clin Oncol 2015 Jan 20;33(2):149-55. Epub 2014 Oct 20.

Scott D. Ramsey, Julie R. Gralow, Dana K. Mirick, William Barlow, Ruth Etzioni, and David Mummy, Fred Hutchinson Cancer Research Center; Scott D. Ramsey, Julie R. Gralow, Rahber Thariani, and David L. Veenstra, University of Washington, Seattle, WA; and N. Lynn Henry, University of Michigan, Ann Arbor, MI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2014.55.5409DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279234PMC
January 2015

Challenges in evaluating next-generation sequence data for clinical decisions.

Nurs Outlook 2015 Jan-Feb;63(1):48-50. Epub 2014 Aug 23.

University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.outlook.2014.08.007DOI Listing
November 2015

Cost-effectiveness of recombinant tissue-type plasminogen activator within 3 hours of acute ischemic stroke: current evidence.

Stroke 2014 Oct 4;45(10):3032-9. Epub 2014 Sep 4.

From the University of Washington, Seattle (D.M.B., G.F.G., D.L.V.); Genentech, Inc South San Francisco, CA (E.C., D.T.); Palo Alto Outcomes Research, CA (D.L.); and University of Georgia College of Pharmacy, Athens (S.C.F.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/STROKEAHA.114.005852DOI Listing
October 2014

Long-term survival in patients with severe acute respiratory distress syndrome and rescue therapies for refractory hypoxemia*.

Crit Care Med 2014 Jul;42(7):1610-8

1Department of Anesthesiology and Pain Medicine, University of Washington, Harborview Medical Center, Seattle, WA. 2Division of Pulmonary and Critical Care Medicine, University of Washington, Harborview Medical Center, Seattle, WA. 3Department of Biostatistics, University of Washington, Seattle, WA. 4Department of Pharmacy, University of Washington, Seattle, WA. 5Department of Epidemiology, University of Washington, Seattle, WA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CCM.0000000000000322DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061153PMC
July 2014

Targeted erlotinib for first-line treatment of advanced non-small cell lung cancer: a budget impact analysis.

J Med Econ 2014 Aug 12;17(8):538-46. Epub 2014 May 12.

University of Washington, Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy , Seattle, WA 98195 , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3111/13696998.2014.912987DOI Listing
August 2014

Cost-effectiveness of pharmacogenetic-guided dosing of phenprocoumon in atrial fibrillation.

Pharmacogenomics 2013 Jun;14(8):869-83

Utrecht Institute of Pharmaceutical Sciences, Division of Pharmacoepidemiology & Clinical Pharmacology, Utrecht University, PO Box 80 082, 3508 TB Utrecht, The Netherlands.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/pgs.13.74
Publisher Site
http://dx.doi.org/10.2217/pgs.13.74DOI Listing
June 2013

The validity of dependence as a health outcome measure in Alzheimer's disease.

Am J Alzheimers Dis Other Demen 2013 May 19;28(3):245-52. Epub 2013 Mar 19.

Centre for Health Economics, University of York, Hesslington,York, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1533317513481092DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3690581PMC
May 2013

Navigational bronchoscopy with biopsy versus computed tomography-guided biopsy for the diagnosis of a solitary pulmonary nodule: a cost-consequences analysis.

J Bronchology Interv Pulmonol 2012 Oct;19(4):294-303

Division of Pulmonary and Critical Care Medicine, Harborview Medical Center, University of Washington, Seattle, WA 98104, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/LBR.0b013e318272157dDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3611239PMC
October 2012

A risk-benefit analysis of factor V Leiden testing to improve pregnancy outcomes: a case study of the capabilities of decision modeling in genomics.

Genet Med 2013 May 8;15(5):374-81. Epub 2012 Nov 8.

Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/gim.2012.139DOI Listing
May 2013

The value of comparative effectiveness research: projected return on investment of the RxPONDER trial (SWOG S1007).

Contemp Clin Trials 2012 Nov 18;33(6):1117-23. Epub 2012 Aug 18.

Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cct.2012.08.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3486702PMC
November 2012

Improving the efficiency and relevance of evidence-based recommendations in the era of whole-genome sequencing: an EGAPP methods update.

Genet Med 2013 Jan 6;15(1):14-24. Epub 2012 Sep 6.

Department of Pharmacy, Pharmaceutical Outcomes Research and Policy Program, Institute for Public Health Genetics, University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/gim.2012.106DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3932295PMC
January 2013

Stakeholder perspectives on decision-analytic modeling frameworks to assess genetic services policy.

Genet Med 2013 Jan 26;15(1):84-7. Epub 2012 Jul 26.

Center for Genomics and Healthcare Equality, University of Washington, Seattle, Washington, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/gim.2012.92DOI Listing
January 2013

Stakeholder participation in comparative effectiveness research: defining a framework for effective engagement.

J Comp Eff Res 2012 Mar;1(2):181-194

Center for Medical Technology Policy, 401 East Pratt Street, Suite 631, Baltimore, MD 21202-3117, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/cer.12.7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371639PMC
March 2012

The cost-effectiveness of primary stroke centers for acute stroke care.

Stroke 2012 Jun 25;43(6):1617-23. Epub 2012 Apr 25.

University of Washington, Seattle, WA 98195,USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/STROKEAHA.111.648238DOI Listing
June 2012

Systematic review of comparative effectiveness data for oncology orphan drugs.

Am J Manag Care 2012 Jan;18(1):47-62

Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA 98195-7630, USA.

View Article

Download full-text PDF

Source
January 2012

Paying for personalized care: cancer biomarkers and comparative effectiveness.

Mol Oncol 2012 Apr 6;6(2):260-6. Epub 2012 Mar 6.

Department of Pharmacy, University of Washington, Seattle, WA 98195-7630, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2012.02.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593045PMC
April 2012

A network meta-analysis of therapies for previously untreated chronic lymphocytic leukemia.

Cancer Treat Rev 2012 Dec 9;38(8):1004-11. Epub 2012 Mar 9.

University of Washington, Department of Pharmacy, Box 357630, Seattle, WA 98195-7630, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2012.02.006DOI Listing
December 2012

Potential cost-effectiveness of universal access to modern contraceptives in Uganda.

PLoS One 2012 17;7(2):e30735. Epub 2012 Feb 17.

Global Medicines Program, Department of Global Health, School of Public Health, University of Washington, Seattle, Washington, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0030735PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281877PMC
June 2012

Estimating the costs of induced abortion in Uganda: a model-based analysis.

BMC Public Health 2011 Dec 6;11:904. Epub 2011 Dec 6.

Global Medicines Program, Department of Global Health, School of Public Health, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2458-11-904DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3293098PMC
December 2011

Evolving research and stakeholder perspectives on pharmacogenomics.

JAMA 2011 Sep;306(11):1252-3

University of Maryland School of Medicine, Department of Medicine, Baltimore, USA.

View Article

Download full-text PDF

Source
http://jama.jamanetwork.com/article.aspx?doi=10.1001/jama.20
Publisher Site
http://dx.doi.org/10.1001/jama.2011.1343DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3559013PMC
September 2011

Fondaparinux for isolated superficial vein thrombosis of the legs: a cost-effectiveness analysis.

Chest 2012 Feb 14;141(2):321-329. Epub 2011 Jul 14.

Department of Pharmacy, University of Washington, Seattle.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1378/chest.11-0625DOI Listing
February 2012

Using cost-effectiveness analysis to support research and development portfolio prioritization for product innovations in measles vaccination.

J Infect Dis 2011 Jul;204 Suppl 1:S124-32

Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy, University of Washington, Seattle, WA 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/infdis/jir114DOI Listing
July 2011

CDR state transition probabilities in Alzheimer's disease with and without cholinesterase inhibitor intervention in an observational cohort.

J Alzheimers Dis 2011 ;24(3):599-607

Pharmaceutical Outcomes Research and Policy Program, University of Washington, Seattle, WA 98195-7630, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/JAD-2011-101758DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3593724PMC
September 2011

Budget impact of erlotinib for maintenance therapy in advanced non-small cell lung cancer.

J Med Econ 2011 2;14(2):159-66. Epub 2011 Feb 2.

University of Washington, Pharmaceutical Outcomes Research and Policy Program, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3111/13696998.2011.557457DOI Listing
July 2011

Feasibility of incorporating genomic knowledge into electronic medical records for pharmacogenomic clinical decision support.

BMC Bioinformatics 2010 Oct 28;11 Suppl 9:S10. Epub 2010 Oct 28.

Department of Medical Education & Biomedical Informatics, University of Washington, Seattle, WA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2105-11-S9-S10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2967740PMC
October 2010

Cost effectiveness of pharmacogenomics: a critical and systematic review.

Pharmacoeconomics 2010 ;28(11):1001-13

University of Washington, Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy, Seattle, Washington 98195-7630, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/11537410-000000000-00000DOI Listing
October 2011

Stakeholder perspectives on a risk-benefit framework for genetic testing.

Public Health Genomics 2011 20;14(2):59-67. Epub 2010 Apr 20.

Department of Pharmacy, University of Washington, Seattle, WA 98195, USA.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/290452
Publisher Site
http://dx.doi.org/10.1159/000290452DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3214932PMC
June 2011

Linking payment to health outcomes: a taxonomy and examination of performance-based reimbursement schemes between healthcare payers and manufacturers.

Health Policy 2010 Aug 11;96(3):179-90. Epub 2010 Mar 11.

Pharmaceutical Outcomes Research and Policy Program, University of Washington, 1959 NE Pacific Street, Seattle, WA 98195-7630, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.healthpol.2010.02.005DOI Listing
August 2010

Personalized medicine and genomics: challenges and opportunities in assessing effectiveness, cost-effectiveness, and future research priorities.

Med Decis Making 2010 May-Jun;30(3):328-40. Epub 2010 Jan 4.

Department of Pediatrics and Center for Health and the Social Sciences, University of Chicago, Chicago, Illinois, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0272989X09347014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598076PMC
June 2010

Cost-consequences of ultrafiltration for acute heart failure: a decision model analysis.

Circ Cardiovasc Qual Outcomes 2009 Nov 3;2(6):566-73. Epub 2009 Nov 3.

Health Services Research & Development, VA Puget Sound Health Care System, Seattle, WA 98101, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/CIRCOUTCOMES.109.853556DOI Listing
November 2009

A policy model to evaluate the benefits, risks and costs of warfarin pharmacogenomic testing.

Pharmacoeconomics 2010 ;28(1):61-74

Department of Pharmacy, University of Washington, Seattle, Washington 98195, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2165/11318240-000000000-00000DOI Listing
February 2010

Expectations, validity, and reality in pharmacogenetics.

J Clin Epidemiol 2010 Sep 7;63(9):960-9. Epub 2009 Dec 7.

Department of Neurology, University of Alabama at Birmingham, Birmingham, AL 35294-0021, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jclinepi.2009.09.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2888890PMC
September 2010